| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ACRV | Common Stock | Tax liability | $201,364 | -37,152 | -1.6% | $5.42 | 2,305,685 | 14 Feb 2025 | Direct | F1, F2 |
| transaction | ACRV | Common Stock | Tax liability | $3,138 | -579 | -0.18% | $5.42 | 316,177 | 14 Feb 2025 | See Footnote | F1, F3 |
| Id | Content |
|---|---|
| F1 | Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. |
| F2 | These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. |
| F3 | These securities are held by co-founder and EVP, Dr. Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |